After the threat of tariffs – Novartis invests 230 billion in the USA

Pharmaceutical giant Novartis plans to invest 23 billion dollarsover the next five years to expand its production in the USA. The goal is for all medicines destined for the US market to be produced within the country.

Korbinian Löbmann leads scientific meeting on drug formulation: High activity in the field

Korbinian Löbmann has moderated New Updates in Drug Formulation & Bioavailability several times before. Now he is once again taking on the scientific meeting. Life Science Sweden reached out to him.

Large study on milk: Risky for women but not for men

The risk of ischemic heart disease (IHD) and acute myocardial infarction (MI) increased for women with milk intake levels higher than 2 glasses per day, while no such association was found in men, according to a new large Swedish study.

Study names with an attitude – more important than you might think

Ironman, T-rex, Star-Trek. Popcorn, Proper, Scout. Nope, these are neither fantasy films nor dog names. They’re the names of ongoing cancer studies in Sweden.

The first Lyme disease vaccine faces a delay

Pfizer and Valneva’s Lyme disease vaccine, which could be the first of its kind, is facing delays of about a year. The reason is problems at trial sites in the United States, which have forced the companies to drop half of the participants in an ongoing Phase III study.

AI baserad på språkalgoritm skapade nya fungerande proteiner

Inte ens proteiner går säkra för språkrobotarna. I det senaste numret av Nature Biotechnology presenterades språkmodellen Progen som, enligt forskarna bakom studien, lärt sig semantiken och grammatiken i proteinernas språk.

A growing industry in Denmark: “One new life science company a week”

The life science sector in eastern Denmark continues to grow in the number of employees, as well as the number of companies. An emerging problem is the shortage of labour, a new report reveals.

Noxious parasite forms hybrids and deceives the immune system

The small parasite Trypanosoma cruzi has a nasty ability to cause serious illness. Researchers at the Karolinska Institutet have now mapped its ability to deceive the immune system by forming new variants that are mixtures of different strains.

Investments worth 40 billion in the Öresund region – “A huge investment wave”

A new report reveals that medical companies in the Oresund region are investing like never before.

Elicera develops CAR-T against solid tumours – may become the first in the world

Today, there are five EU-approved CAR-T therapies, all focused on different types of blood cancer, but no one has yet succeeded in making the method work against solid tumours. At Gothenburg-based Elicera, they are working relentlessly to succeed in that field as well. “It is the largest field, and the potential is enormous,” says the company’s CEO Jamal El-Mosleh.

Björn Arvidsson: ”We need to change perspective”

If you say “life science” to a person on the street and ask them to explain what it is, you will probably get no good answer. The same question to your network will generate as many versions as the people you ask. Most likely, we will miss many

Så försvarar du företaget mot årets säkerhetshot

Det globala tekniktjänstföretaget NTT Ltd. har identifierat fem cybersäkerhetshot som kan komma att prägla 2022 och hur man skyddar sig mot dem.

Sweden and Denmark – this is how they choose their strategies

Scandinavia’s two major powers in pharmaceutical research have developed strategies for growth in life science, and both countries aim to become world leaders.

Norway finds its path in life science

The life science sector in Norway is on the rise.

Olinks plattform ska användas i stort brittiskt analysprojekt

Genom att analysera proteinplasma från 53 000 britter hoppas de tio deltagande biofarmabolagen utveckla bättre läkemedel.

Krönika: Collaboration across borders

Gastillverkning i labbet

IATT:s gasgeneratorserie Airogen tar bort behovet av gascylindrar för vätgas, kvävgas och ultraren luft.

De får Forska och Väx-pengar

59 företag får dela på 66 miljoner kronor i senaste Vinnova-utdelningen. 20 är life science-företag.

Droppbaserad PCR tillåter exakt molekylkvantifiering

Arbete i mindre volymer har visat sig vara nödvändigt för att uppnå de tilltagande kraven på singel-molekylkänslighet som finns inom life science. Detta återspeglas tydligt även i traditionella tekniker som kvantitativ PCR.

New partnering platform

EBD Group's Partnering One is the new partnering platform for Biotech Forum 2009.

Multilabel plate readers with luminescence capability

The Enspire Multilabel Plate Reader platform from Perkin Elmer now features sensitive luminescence detection. The new detection capability is primarily aimed at improving assay performance and sensitivity for scientists working with primary cells or stem cells in cancer and neuropharmacology research.

Raka spåret in i USA

Euris sluter avtal med det amerikanska bolaget Ocean Nano Tech, som ska distribuera bolagets produkter på den amerikanska marknaden.

Trio goes in for high tech medicines

The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.

Collaboration brings next generation drugs

Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.